Clinical data | |
---|---|
Trade names | Libexin |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H27N3O |
Molar mass | 361.489 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Prenoxdiazine (marketed as Libexin) is a cough suppressant. It acts peripherally by desensitizing the pulmonary stretch receptors. Therefore, there's a reduction of cough impulses originating in the lungs. Prenoxdiazine is indicated in cough of bronchial origin.
References
- Csürös L (1989). "Fifteen years of experience on the use of Libexin tablets". Therapia Hungarica. 37 (1): 50–4. PMID 2667194.
This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |